癫痫市场、癫痫市场规模、癫痫市场份额、癫痫市场预测、癫痫市场增长、癫痫市场分析市场基于(主要区域、市场参与者、规模和份额) - 预测复合年增长率为 4.10%

  • Report Code : TIPRE00016405
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

癫痫市场规模预计将从 2023 年的 80.3 亿美元增至 2031 年的 107 亿美元。预计 2023-2031 年市场复合年增长率为 4.10%。推动市场增长的关键因素是癫痫患病率上升以及癫痫疗法开发投资的增加。然而,产品召回可能会在一定程度上阻碍市场增长。

癫痫市场分析

癫痫也称为癫痫症,是一种影响大脑的慢性非传染性疾病。癫痫症影响所有种族、民族背景、性别和年龄的人。据美国疾病控制与预防中心估计,美国有 1.2% 的人患有活动性癫痫。

癫痫市场概述

癫痫可能是由于某些遗传性疾病或某些后天性脑损伤(例如外伤或中风)引起的。根据世界卫生组织 (WHO) 于 2023 年 2 月发布的最新报告,癫痫在全球疾病负担中占据很大一部分,影响着全球近 5000 万人。此外,估计每 1,000 人中有 4-10 人患有活动性癫痫(即需要治疗或持续癫痫发作)。每年有近 500 万人被诊断患有癫痫症。据估计,高收入国家每年每 10 万人中有 49 人患有高发癫痫症。在低收入和中等收入国家,这一数字可达每 10 万人中 139 人。癫痫发病率激增可归因于道路交通伤害和出生相关伤害的增加,以及神经囊尾蚴病或疟疾等地方性疾病的风险增加。世界卫生组织还指出,大约 70% 的癫痫患者可以通过药物治疗消除癫痫发作。

控制癫痫的治疗方法包括抗癫痫药物、特殊饮食(除抗癫痫药物外)和手术;然而,抗癫痫药物治疗是大多数患者的主要治疗方法。因此,全球癫痫患病率的上升推动了市场的增长。

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

癫痫市场:

癫痫市场

  • 年均复合增长率(2023 - 2031)
    4.10%
  • 2023 年市场规模
    80.3 亿美元
  • 2031 年市场规模
    107 亿美元

市场动态

增长动力
  • 治疗癫痫的细胞和基因疗法
未来的趋势
  • 各个政府和私人组织开展的关于癫痫诊断和治疗增加的提高认识计划为市场提供了利润丰厚的增长机会
机会
  • 基因治疗可能成为未来几年癫痫市场有前景的新趋势

关键人物;主力;重要一员

  • Idexx 实验室公司
  • PBD生物科技有限公司
  • 赛默飞世尔科技公司
  • 创新诊断 SAS
  • 纽勤公司
  • 恩弗实验室
  • 生物梅里埃公司
  • 瑞林生物科技有限公司
  • 比奥诺特公司
  • 深圳市易瑞生物科技有限公司

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

类型
  • 进行性肌阵挛癫痫
  • 反射性癫痫
  • 全身性癫痫
  • 其他
给药途径
  • 口服
  • 注射用
治疗类型
  • 第一代药物
  • 第二代药物
  • 第三代药物
年龄阶层
  • 成年人
  • 孩子们
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

癫痫市场驱动因素和机遇

增加对癫痫疗法开发的投资有利于市场

随着技术的快速发展和创新,医疗保健行业正在发生变革,提高了医疗保健服务和护理质量。癫痫市场的特点是有多家小型和大型公司和组织实施各种增长战略。资金的可用性使公司和组织能够提高生产水平,拓展新市场,投资新的/改进的技术,并为研发分配更多资源。下面提到了癫痫市场上一些对市场进步做出贡献的著名投资

  • 2023年3月,瑞典政府决定委托瑞典创新机构Vinnova拨款770万美元(8000万瑞典克朗)建立国家创新集群,用于细胞疗法和药物的商业化、技能开发和生产能力建设。其他先进疗法,例如基因疗法。
  • 2022 年 11 月,英国阿斯顿大学的科学家们致力于开发预防儿童癫痫发作的新药物治疗项目,获得了 240 万美元(200 万英镑)的资助,以发现大脑中的疾病机制和预防癫痫的方法。这个为期三年的项目由医学研究委员会资助,由阿斯顿大学健康与生命科学学院的研究人员与布里斯托尔大学和 Jazz Pharmaceutical 联合领导。

组织开展的意识计划——癫痫市场的机会

人们对癫痫及其症状以及早期诊断重要性的认识不断提高,导致寻求医疗救助的患者数量激增。癫痫基金会、癫痫协会、美国癫痫协会和佛罗里达州中部癫痫协会等组织在教育人们了解这种疾病方面发挥着至关重要的作用。这些组织的参与提高了诊断率,并扩大了需要癫痫治疗的患者群体。

全球各地的组织开展了许多宣传活动,以提高人们对疾病状况和可用治疗的认识。在美国,每年 3 月 26 日都会设立“癫痫意识日”或“紫色日”,以提高公众对这种脑部疾病的了解,并消除对其的恐惧和耻辱。同样,每年 11 月在美国被定为全国癫痫意识月 (NEAM),以教育人们了解癫痫的状况和症状,并为与控制这种疾病相关的研究筹集资金。癫痫基金会选择的主题鼓励人们合作并采取行动,以提高人们对癫痫的认识并为其提供资金。 2021 年 11 月,该基金会发起了#RemoveTheFilter 社交媒体活动,以减少与癫痫相关的恐惧,并为患有该疾病的人们带来希望。

此外,癫痫基金会与 SK Life Science Inc. 合作推出了 30 分钟的点播课程,供人们学习癫痫急救的要点。 10 月 23 日是英国癫痫猝死 (SUDEP) 宣传日。SUDEP 行动促使国际癫痫界认识并提高对癫痫引起的猝死和意外死亡的认识。因此,此类举措和宣传活动增加了癫痫的诊断和治疗,为市场提供了利润丰厚的增长机会。

癫痫市场报告细分分析

有助于癫痫市场分析的关键部分是类型、给药途径、治疗类型、年龄组和分销渠道。

  • 根据类型,癫痫市场分为进行性肌阵挛性癫痫、反射性癫痫、全身性癫痫等。 2023 年,全身性癫痫细分市场占据更高的市场份额。
  •  根据给药途径,市场分为口服、肠胃外和其他给药途径。
  • 从治疗类型来看,市场分为第一代药物、第二代药物和第三代药物。
  • 从年龄层来看,市场分为成人和儿童。
  • 从分销渠道来看,市场细分为医院药房、零售药店和其他分销渠道

按地域划分的癫痫市场份额分析

癫痫市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲、南美洲/中南美洲。

在北美,癫痫市场目前在预测年内正在经历指数级增长。到2023年,美国市场将主导全球癫痫市场。阿尔茨海默氏病等神经系统疾病病例数量的迅速增加、人们对神经系统疾病的认识不断提高、研究活动取得的良好成果以及对开发癫痫药物的投资不断增加是推动这一趋势的主要因素。美国癫痫市场的整体增长。 2020 年 3 月,Neurelis, Inc. 宣布 VALTOCO(地西泮鼻喷雾剂)上市,用于治疗与儿科和儿童中观察到的常见癫痫发作模式不同的频繁发作的刻板间歇性发作(即急性重复性癫痫发作和丛集性癫痫发作)。成年患者。同样,2022 年 3 月,FDA 批准 Ztalmy(加奈索酮)用于治疗 2 岁及以上患者与细胞周期蛋白依赖性激酶样 5 (CDKL5) 缺乏症 (CDD) 相关的癫痫发作。

2021 年 8 月,CDC 癫痫项目根据一项新的合作协议选择癫痫基金会作为其资金接受者:通过国家和社区伙伴关系改善护理系统、癫痫教育和健康结果。未来 5 年将分配 1750 万美元的联邦资金,用于支持癫痫基金会及其合作伙伴的工作,创建和维护强大的公共卫生基础设施,促进健康公平,改善生活质量,并实现为所有癫痫患者带来最佳结果。因此,癫痫患病率的不断上升、新药的推出以及研究和资助计划增强了美国癫痫市场的规模。

癫痫市场报告范围

报告属性细节
2023年市场规模80.3亿美元
2031 年市场规模107亿美元
全球复合年增长率(2023 - 2031)4.10%
历史数据2021-2022
预测期2023-2031
涵盖的细分市场按类型
  • 进行性肌阵挛癫痫
  • 反射性癫痫
  • 全身性癫痫
  • 其他
按给药途径
  • 口服
  • 注射用
按治疗类型
  • 第一代药物
  • 第二代药物
  • 第三代药物
按年龄段
  • 成年人
  • 孩子们
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • Idexx 实验室公司
  • PBD生物科技有限公司
  • 赛默飞世尔科技公司
  • 创新诊断 SAS
  • 纽勤公司
  • 恩弗实验室
  • 生物梅里埃公司
  • 瑞林生物科技有限公司
  • 比奥诺特公司
  • 深圳市易瑞生物科技有限公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

癫痫市场新闻和最新动态

癫痫市场是通过收集初级和二级研究后的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。以下是创新、业务扩展和战略市场发展的列表:

  • 2023 年 5 月,专注于寻找和创造治疗中枢神经系统疾病的新型药物的生物技术公司 Neuro3 Therapeutics (Neuro3) 与 Lundbeck 签署了独家全球许可和期权协议。该协议重点关注KCNQ2离子通道激活剂,该激活剂已被临床验证为癫痫治疗的靶点。根据临床研究,KCNQ2 通道激活可能为治疗各种神经系统疾病(例如罕见形式的癫痫)提供治疗替代方案。 (来源:Neuro3 Therapeutics 公司网站)

癫痫市场报告范围和交付成果

《癫痫市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

范围内涵盖的所有关键细分市场的全球、区域和国家层面的癫痫市场规模和预测

  • 市场动态,例如驱动因素、限制因素和关键机遇

癫痫市场趋势

  • 详细的 PEST/波特五力分析和 SWOT 分析

癫痫市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展

癫痫行业格局和竞争分析,包括市场集中度、热图分析、知名参与者和最新发展

  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the epilepsy market in 2023?

North America dominated the epilepsy market in 2023

What are the driving factors impacting the epilepsy market?

The rising prevalence of epilepsy and increasing investments in development of epilepsy therapies are the major factors fuelling the market growth of epilepsy over the years.

What are the future trends of the epilepsy market?

The high-throughput genetic sequencing technique enables a faster and more comprehensive analysis of DNA, thereby aiding the identification of genetic causes of conditions such as epilepsy are likely to remain a key trend in the market.

Which are the leading players operating in the epilepsy market?

Abbott Laboratories, Pfizer Inc., Eisai Co Ltd., UCB SA, CombiGene AB, LivaNova Plc, Novartis AG, Medtronic Plc, GSK Plc, and H. Lundbeck AS

What is the expected CAGR of the epilepsy market?

The market is expected to register a CAGR of 4.10% during 2023–2031.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports